Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / May 25, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Biohaven Pharmaceutical Holding Compa...
The U.S. Food and Drug Administration (FDA) accepted for review Biohaven Pharmaceutical's (NYSE:BHVN) application seeking approval of zavegepant nasal spray for the acute treatment of migraine in adults. The FDA is expected to make a decision on the new drug application (NDA) in Q1 2023....
Biohaven Pharmaceutical (NYSE:BHVN) reported data from phase 3 trial of its drug troriluzole in patients with spinocerebellar ataxia (SCA), a group of inherited disorder affecting walk, speech and coordination of hands and legs. The company said the main goal, of change in function,...
US FDA Accepts for Review Biohaven's New Drug Application (NDA) Filing of Intranasal Zavegepant for the Acute Treatment of Migraine PR Newswire If approved, zavegepant nasal spray would be the only FDA-approved CGRP receptor antagonist in an intranasal formulation, g...
Biohaven Provides Update on Phase 3 Clinical Trial Evaluating Troriluzole for Spinocerebellar Ataxia (SCA) PR Newswire NEW HAVEN, Conn. , May 23, 2022 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced top-line resul...
Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In what turned out to be a challenging first quarter, Baron Discovery Fund (the “Fund”) decreased 16.30% (I...
NEW YORK, NY / ACCESSWIRE / May 18, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Biohaven Pharmaceutical Holding Compa...
S3 Partners ran an intriguing screen to find the most crowded shorts in the market. In looking at the stocks under attack, the firm said a short can be considered to be "crowded" if there are large amount of dollars at risk on the short side, a large proportion of a stock's float is being sho...
Eight new deals announced last week. Chicken Soup acquires Redbox in a 'take-under' at a massive discount. Following Elon Musk's tweet last week, stating that the Twitter deal is temporarily on hold, Twitter shares fell as low as $40.01 on Friday, May 13, 2022. For further d...
Do You Have These Top Biotech Stocks On Your Watchlist? Depending on your investment appetite, the stock market offers various types of opportunities. Biotech stocks have a reputation for being a high-risk, high-reward sector to invest in. This is an industry that includes compa...
News, Short Squeeze, Breakout and More Instantly...
Biohaven Pharmaceutical Holding Company Ltd. Company Name:
BHVN Stock Symbol:
NYSE Market:
Biohaven Pharmaceutical Holding Company Ltd. Website:
2024-05-29 12:00:07 ET Brian Skorney from Robert W. Baird issued a price target of $58.00 for BHVN on 2024-05-29 09:57:00. The adjusted price target was set to $58.00. At the time of the announcement, BHVN was trading at $30.31. The overall price target consensus is at $...
2024-05-29 11:00:21 ET Leonid Timashev from RBC Capital issued a price target of $59.00 for BHVN on 2024-05-29 09:14:00. The adjusted price target was set to $59.00. At the time of the announcement, BHVN was trading at $28.69. The overall price target consensus is at $23...